Clinical and genetic investigation of 17 Japanese patients with hyperekplexia

Jun Mine, Takeshi Taketani, Kazushi Yoshida, Fusako Yokochi, Junpei Kobayashi, Koichi Maruyama, Etsuro Nanishi, Mayumi Ono, Atsushi Yokoyama, Hidee Arai, Shiho Tamaura, Yasuhiro Suzuki, Shusuke Otsubo, Takashi Hayashi, Masahiko Kimura, Kazuko Kishi, Seiji Yamaguchi

研究成果: ジャーナルへの寄稿記事

9 引用 (Scopus)

抄録

Aim: The aim of the study was to determine clinical and genetic characteristics of Japanese patients with hyperekplexia. Method: Clinical courses, responses to antiepileptic drugs, outcomes, and genetic testing were investigated in 17 Japanese patients (nine males, eight females, median age 1y, range birth-45y) with hyperekplexia. Results: In all patients, muscle stiffness and startle responses appeared soon after birth. Only seven patients were diagnosed with hyperekplexia before 1 year of age. Seven patients had been misdiagnosed with other disorders such as epilepsy and adult-onset anxiety neurosis. Umbilical/inguinal hernias were seen in 10 patients. Life-threatening events were noted in four patients. Clonazepam was the most effective drug. Muscle stiffness completely disappeared in 12 patients before 5 years of age, whereas startle responses resolved in only three patients. Mutations in the GLRA1 and GLRB genes were identified in 16 patients and one patient respectively. In 14 patients, the mutation showed autosomal dominant inheritance; in the other three, inheritance was autosomal recessive. p.R271Q of GLRA1 was the most frequent mutation, found in 10 patients. Novel mutations, p.A272P and p.A384P of GLRA1, were detected. Clinical severity and outcome varied even in the same family. Interpretation: Early correct diagnosis is essential for prevention of accidental injuries and to provide appropriate treatments for hyperekplexia. Clonazepam is effective, although the time taken for startle responses to resolve varied.

元の言語英語
ページ(範囲)372-377
ページ数6
ジャーナルDevelopmental Medicine and Child Neurology
57
発行部数4
DOI
出版物ステータス出版済み - 4 1 2015
外部発表Yes

Fingerprint

Startle Reflex
Clonazepam
Mutation
Hyperekplexia
Parturition
Umbilical Hernia
Muscles
Inguinal Hernia
Genetic Testing
Anxiety Disorders
Diagnostic Errors
Anticonvulsants
Early Diagnosis
Epilepsy
Wounds and Injuries
Pharmaceutical Preparations
Genes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Clinical Neurology

これを引用

Mine, J., Taketani, T., Yoshida, K., Yokochi, F., Kobayashi, J., Maruyama, K., ... Yamaguchi, S. (2015). Clinical and genetic investigation of 17 Japanese patients with hyperekplexia. Developmental Medicine and Child Neurology, 57(4), 372-377. https://doi.org/10.1111/dmcn.12617

Clinical and genetic investigation of 17 Japanese patients with hyperekplexia. / Mine, Jun; Taketani, Takeshi; Yoshida, Kazushi; Yokochi, Fusako; Kobayashi, Junpei; Maruyama, Koichi; Nanishi, Etsuro; Ono, Mayumi; Yokoyama, Atsushi; Arai, Hidee; Tamaura, Shiho; Suzuki, Yasuhiro; Otsubo, Shusuke; Hayashi, Takashi; Kimura, Masahiko; Kishi, Kazuko; Yamaguchi, Seiji.

:: Developmental Medicine and Child Neurology, 巻 57, 番号 4, 01.04.2015, p. 372-377.

研究成果: ジャーナルへの寄稿記事

Mine, J, Taketani, T, Yoshida, K, Yokochi, F, Kobayashi, J, Maruyama, K, Nanishi, E, Ono, M, Yokoyama, A, Arai, H, Tamaura, S, Suzuki, Y, Otsubo, S, Hayashi, T, Kimura, M, Kishi, K & Yamaguchi, S 2015, 'Clinical and genetic investigation of 17 Japanese patients with hyperekplexia', Developmental Medicine and Child Neurology, 巻. 57, 番号 4, pp. 372-377. https://doi.org/10.1111/dmcn.12617
Mine J, Taketani T, Yoshida K, Yokochi F, Kobayashi J, Maruyama K その他. Clinical and genetic investigation of 17 Japanese patients with hyperekplexia. Developmental Medicine and Child Neurology. 2015 4 1;57(4):372-377. https://doi.org/10.1111/dmcn.12617
Mine, Jun ; Taketani, Takeshi ; Yoshida, Kazushi ; Yokochi, Fusako ; Kobayashi, Junpei ; Maruyama, Koichi ; Nanishi, Etsuro ; Ono, Mayumi ; Yokoyama, Atsushi ; Arai, Hidee ; Tamaura, Shiho ; Suzuki, Yasuhiro ; Otsubo, Shusuke ; Hayashi, Takashi ; Kimura, Masahiko ; Kishi, Kazuko ; Yamaguchi, Seiji. / Clinical and genetic investigation of 17 Japanese patients with hyperekplexia. :: Developmental Medicine and Child Neurology. 2015 ; 巻 57, 番号 4. pp. 372-377.
@article{69cb3d1a37a94817b45bdc268014d0f8,
title = "Clinical and genetic investigation of 17 Japanese patients with hyperekplexia",
abstract = "Aim: The aim of the study was to determine clinical and genetic characteristics of Japanese patients with hyperekplexia. Method: Clinical courses, responses to antiepileptic drugs, outcomes, and genetic testing were investigated in 17 Japanese patients (nine males, eight females, median age 1y, range birth-45y) with hyperekplexia. Results: In all patients, muscle stiffness and startle responses appeared soon after birth. Only seven patients were diagnosed with hyperekplexia before 1 year of age. Seven patients had been misdiagnosed with other disorders such as epilepsy and adult-onset anxiety neurosis. Umbilical/inguinal hernias were seen in 10 patients. Life-threatening events were noted in four patients. Clonazepam was the most effective drug. Muscle stiffness completely disappeared in 12 patients before 5 years of age, whereas startle responses resolved in only three patients. Mutations in the GLRA1 and GLRB genes were identified in 16 patients and one patient respectively. In 14 patients, the mutation showed autosomal dominant inheritance; in the other three, inheritance was autosomal recessive. p.R271Q of GLRA1 was the most frequent mutation, found in 10 patients. Novel mutations, p.A272P and p.A384P of GLRA1, were detected. Clinical severity and outcome varied even in the same family. Interpretation: Early correct diagnosis is essential for prevention of accidental injuries and to provide appropriate treatments for hyperekplexia. Clonazepam is effective, although the time taken for startle responses to resolve varied.",
author = "Jun Mine and Takeshi Taketani and Kazushi Yoshida and Fusako Yokochi and Junpei Kobayashi and Koichi Maruyama and Etsuro Nanishi and Mayumi Ono and Atsushi Yokoyama and Hidee Arai and Shiho Tamaura and Yasuhiro Suzuki and Shusuke Otsubo and Takashi Hayashi and Masahiko Kimura and Kazuko Kishi and Seiji Yamaguchi",
year = "2015",
month = "4",
day = "1",
doi = "10.1111/dmcn.12617",
language = "English",
volume = "57",
pages = "372--377",
journal = "Developmental Medicine and Child Neurology",
issn = "0012-1622",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Clinical and genetic investigation of 17 Japanese patients with hyperekplexia

AU - Mine, Jun

AU - Taketani, Takeshi

AU - Yoshida, Kazushi

AU - Yokochi, Fusako

AU - Kobayashi, Junpei

AU - Maruyama, Koichi

AU - Nanishi, Etsuro

AU - Ono, Mayumi

AU - Yokoyama, Atsushi

AU - Arai, Hidee

AU - Tamaura, Shiho

AU - Suzuki, Yasuhiro

AU - Otsubo, Shusuke

AU - Hayashi, Takashi

AU - Kimura, Masahiko

AU - Kishi, Kazuko

AU - Yamaguchi, Seiji

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Aim: The aim of the study was to determine clinical and genetic characteristics of Japanese patients with hyperekplexia. Method: Clinical courses, responses to antiepileptic drugs, outcomes, and genetic testing were investigated in 17 Japanese patients (nine males, eight females, median age 1y, range birth-45y) with hyperekplexia. Results: In all patients, muscle stiffness and startle responses appeared soon after birth. Only seven patients were diagnosed with hyperekplexia before 1 year of age. Seven patients had been misdiagnosed with other disorders such as epilepsy and adult-onset anxiety neurosis. Umbilical/inguinal hernias were seen in 10 patients. Life-threatening events were noted in four patients. Clonazepam was the most effective drug. Muscle stiffness completely disappeared in 12 patients before 5 years of age, whereas startle responses resolved in only three patients. Mutations in the GLRA1 and GLRB genes were identified in 16 patients and one patient respectively. In 14 patients, the mutation showed autosomal dominant inheritance; in the other three, inheritance was autosomal recessive. p.R271Q of GLRA1 was the most frequent mutation, found in 10 patients. Novel mutations, p.A272P and p.A384P of GLRA1, were detected. Clinical severity and outcome varied even in the same family. Interpretation: Early correct diagnosis is essential for prevention of accidental injuries and to provide appropriate treatments for hyperekplexia. Clonazepam is effective, although the time taken for startle responses to resolve varied.

AB - Aim: The aim of the study was to determine clinical and genetic characteristics of Japanese patients with hyperekplexia. Method: Clinical courses, responses to antiepileptic drugs, outcomes, and genetic testing were investigated in 17 Japanese patients (nine males, eight females, median age 1y, range birth-45y) with hyperekplexia. Results: In all patients, muscle stiffness and startle responses appeared soon after birth. Only seven patients were diagnosed with hyperekplexia before 1 year of age. Seven patients had been misdiagnosed with other disorders such as epilepsy and adult-onset anxiety neurosis. Umbilical/inguinal hernias were seen in 10 patients. Life-threatening events were noted in four patients. Clonazepam was the most effective drug. Muscle stiffness completely disappeared in 12 patients before 5 years of age, whereas startle responses resolved in only three patients. Mutations in the GLRA1 and GLRB genes were identified in 16 patients and one patient respectively. In 14 patients, the mutation showed autosomal dominant inheritance; in the other three, inheritance was autosomal recessive. p.R271Q of GLRA1 was the most frequent mutation, found in 10 patients. Novel mutations, p.A272P and p.A384P of GLRA1, were detected. Clinical severity and outcome varied even in the same family. Interpretation: Early correct diagnosis is essential for prevention of accidental injuries and to provide appropriate treatments for hyperekplexia. Clonazepam is effective, although the time taken for startle responses to resolve varied.

UR - http://www.scopus.com/inward/record.url?scp=84925072713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925072713&partnerID=8YFLogxK

U2 - 10.1111/dmcn.12617

DO - 10.1111/dmcn.12617

M3 - Article

VL - 57

SP - 372

EP - 377

JO - Developmental Medicine and Child Neurology

JF - Developmental Medicine and Child Neurology

SN - 0012-1622

IS - 4

ER -